Yuhan Corp., one of South Korea's leading pharmaceutical company, announced on July 31 that it has signed an investment deal with The Straumann Group, the world's largest dental implant manufacturer, to push into the global dental care business.
Under the deal, Straumann will acquire a 34 percent stake in Warantec, a Yuhan subsidiary specializing in dental implant, and be granted exclusive distribution rights to its products outside South Korea.
Yuhan has continued to expand its dental business in South Korea and enter the global market after acquiring Warantec over two years from 2017 to 2018. The company made an equity investment in dental clinic network firm Medipartner Co. in March to strengthen its local business.
In addition, Yuhan is planning to accelerate its dental business through partnership with Straumann. It will establish a total dental care system in the future, which encompasses its own oral care brand “Yuhan Dental Care,” Warantec’s implant brand “Oneplant“ and other dental medicines and medical supplies and components.
A Yuhan official said, “The two-way strategic partnerships with global firm Straumann and dental clinic network firm Medipartner will help us gain ground as a leader in the total dental care market.”